Session Type
Meeting
Search Results for Drug Toxicity
Abstract Number: 458
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Case Presentation: A 90 year old female, with diabetes mellitus type 2, hypertension and osteoporosis presented to our emergency room with altered mental status for 5 days. The patient had been treated for jaw osteonecrosis over the past 6 months which included multiple debridements and IV antibiotics. She was started on IV ertapenem 1g daily […]
Abstract Number: 603
SHM Converge 2024
Case Presentation: A 80 year-old man with past medical history of frontotemporal dementia and seronegative rheumatoid arthritis (RA) presented with a maculopapular rash that started two weeks ago on his back that progressed to his chest, abdomen, neck, face, scalp, and arms. Physical exam also showed oral mucositis. For his RA, he had been on […]
Abstract Number: 781
SHM Converge 2023
Case Presentation: A middle-aged man with a history of heart failure and atrial fibrillation presented to the hospital with subacutely worsening dyspnea. He had hypoxemia, crackles on pulmonary auscultation, and diffuse airspace opacities on chest radiograph. Admission was requested for presumed exacerbation of heart failure. Upon closer examination, he no edema or elevated jugular venous […]
Abstract Number: K48
SHM Converge 2022
Case Presentation: A 42 year-old Caucasian male with a past medical history significant for schizoaffective disorder with command auditory hallucinations, often commanding him to harm himself or others, with multiple suicide attempts by ingestion, and history of poly-substance abuse, was found by his friend on the floor of his apartment, seemingly unconscious, with copious amounts […]
Abstract Number: 1105
Hospital Medicine 2020, Virtual Competition
Case Presentation: An elderly man was diagnosed with clear cell renal cell carcinoma in 1987, and treated with left nephrectomy, though developed multi-organ metastatic disease in 2015. After he did not tolerate initial treatment with sunitinib, he received 15 cycles of NKTR-214 and nivolumab as part of a phase I/II study. Three months after his […]